NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Department of Health and Human Services
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
12/05/2024
Closes
2027-01-07
Eligibility
Eligibility
Native American tribal governments (Federally recognized)Public and State controlled institutions of higher educationState governmentsSpecial district governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationPublic housing authorities/Indian housing authoritiesFor profit organizations other than small businessesSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationCounty governments
Program
Funding area
Health - HL
Opportunity #
PAR-25-026
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov